Voriconazole (Teva Pharmaceuticals USA, Inc.)
Welcome to the PulseAid listing for the Voriconazole drug offered from Teva Pharmaceuticals USA, Inc.. This Azole Antifungal [EPC],Azoles [Chemical/Ingredient],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA],Cytochrome P450 2C9 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Teva Pharmaceuticals USA, Inc. |
NON-PROPRIETARY NAME: | Voriconazole |
SUBSTANCE NAME: | VORICONAZOLE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Azole Antifungal [EPC],Azoles [Chemical/Ingredient],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA],Cytochrome P450 2C9 Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2012-06-01 |
END MARKETING DATE: | 0000-00-00 |
Voriconazole HUMAN PRESCRIPTION DRUG Details:
Item Description | Voriconazole from Teva Pharmaceuticals USA, Inc. |
LABELER NAME: | Teva Pharmaceuticals USA, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50(mg/1) |
START MARKETING DATE: | 2012-06-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0093-5289_e7a6cebc-d4d3-43fe-a01d-c17eb7d27923 |
PRODUCT NDC: | 0093-5289 |
APPLICATION NUMBER: | ANDA091658 |
Other VORICONAZOLE Pharmaceutical Manufacturers / Labelers: